<bill session="109" type="s" number="813" updated="2013-07-19T20:20:30-04:00">
  <state datetime="2005-04-15">REFERRED</state>
  <status>
    <introduced datetime="2005-04-15"/>
  </status>
  <introduced datetime="2005-04-15"/>
  <titles>
    <title as="introduced" type="official">A bill to amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate for lower prices for medicare prescription drugs.</title>
  </titles>
  <sponsor id="300092"/>
  <cosponsors/>
  <actions>
    <action datetime="2005-04-15">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S3747"/>
    </action>
    <action state="REFERRED" datetime="2005-04-15">
      <text>Read twice and referred to the Committee on Finance.</text>
      <reference ref="CR S3747" label="text of measure as introduced"/>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Drug industry"/>
    <term name="Government operations and politics"/>
    <term name="Medicare"/>
    <term name="Pharmacies"/>
    <term name="Prescription pricing"/>
    <term name="Social welfare"/>
  </subjects>
  <amendments/>
  <summary>4/15/2005--Introduced.
Amends title XVIII (Medicare) of the Social Security Act with respect to prescription drug plans to repeal the prohibition against: (1) interference by the Secretary of Health and Human Services with negotiations between drug manufacturers and pharmacies and prescription drug plan sponsors; and (2) the Secretary's requiring a particular formulary or instituting a price structure for the reimbursement of covered Medicare part D (Voluntary Prescription Drug Benefit Program) drugs. Grants the Secretary authority similar to that of other Federal entities that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered part D drugs.</summary>
</bill>
